Nav: Home

Studies examine availability of opioid-overdose antidote at pharmacies

November 13, 2018

Bottom Line: Two studies looked at the availability of naloxone, an antidote for opioid overdoses, from pharmacies in two states that have passed legislation to allow pharmacists to dispense the medication without a physician's prescription.

What: Having access to naloxone can reduce the risk of death from an opioid overdose. Legislation in California has allowed trained pharmacists to provide naloxone without a physician's prescription since 2016. In this study, an anonymous telephone survey of some California community pharmacies was conducted in 2018 with interviewers posing as potential customers who asked pharmacy staff if they could get naloxone without a prescription. Less than 25 percent of about 1,150 retail pharmacies said they were giving naloxone to patients without a physician prescription. Of the pharmacies providing the medication, only about 50 percent had nasal naloxone in stock. Limitations of the study include a lack of data on the reasons why pharmacies weren't providing the naloxone.

Authors: Talia Puzantian, Pharm.D., BCPP, Keck Graduate Institute School of Pharmacy and Health Sciences, Claremont, California, and James J. Gasper, Pharm.D., BCPP, University of California, San Francisco

(doi:10.1001/jama.2018.12291)

What: A second study evaluated naloxone accessibility from chain pharmacies in Texas under a standing order from prescribers almost three years after Texas enacted legislation. Under a standing order, prescribers may authorize pharmacists to dispense naloxone without a prescription. In this study, interviewers posed as customers and spoke to pharmacists about wanting to purchase naloxone to have on hand in the event they had to respond to an opioid overdose. Among about 2,300 pharmacies, 84 percent indicated they would dispense the naloxone and 69 percent of pharmacies had the medication in stock. The study was limited by interviewing only one pharmacist per pharmacy and including only Texas chain pharmacies.

Authors: Kirk E. Evoy, Pharm.D., BCACP, BC-ADM, CTTS, the University of Texas at Austin, and coauthors

(doi:10.1001/jama.2018.15892)

Related Material: The editorial, "Overcoming Inertia to Improve Medication Use and Deprescribing," by Michael A. Steinman, M.D., University of California San Francisco, California, and C. Seth Landefeld, M.D., University of Alabama at Birmingham, is available on the For The Media website.
-end-
To Learn More: The full studies are available on the For The Media website.

Editor's Note:  Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Want to embed a link to these studies in your story? Links will be live at the embargo time

Puzantian study: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12291

Evoy study: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.15892

JAMA

Related Medication Articles:

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.
Pain medication use by children after common surgeries
About 400 caregivers reported pain medication use by children after common surgeries such as hernia, elbow fracture, appendectomy or adenoid removal in this study.
Bringing cancer medication safely to its destination
Treating cancer more selectively and more effectively -- this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Ludwig-Maximilians-Universität München (LMU).
Bullying linked to student's pain medication use
In a school-based survey study of all students in grades 6, 8, and 10 in Iceland, the use of pain medications was significantly higher among bullied students even when controlling for the amount of pain they felt, as well as age, gender, and socioeconomic status.
New medication gives mice bigger muscles
Researchers from Aarhus University, Denmark, have studied a new group of medicinal products which increase the muscle- and bone mass of mice over a few weeks.
More Medication News and Medication Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...